Assessment gallbladder disease proto

General Details:

Name:
Assessment gallbladder disease proto
Steward:
PhenX
Definition:
This measure is used to assess whether the respondent has had symptoms as a result of gallstones or gallbladder problems and to determine whether the respondent received treatment for the gallbladder problem. The interviewer will provide the respondent with a show card containing a diagram of the upper body before asking the first question. Numbers that appear in parentheses after the answer choice are a skip pattern and direct the user to the next question in the series. These questions will not identify asymptomatic gallstones. For a more detailed assessment of gallbladder disease in adults, including identification of subjects with asymptomatic gallstones, see the National Health and Nutrition Examination Survey (NHANES) gallbladder ultrasound protocol in the Gastrointestinal Working Group Supplemental Information.
Registration Status:
Qualified

Designations:

Designation:
Assessment gallbladder disease proto
Tags:
Short Name
Designation:
PhenX - assessment of gallbladder disease and related conditions protocol 190201
Tags:
Long Common Name

Designations:

Definition:
This measure is used to assess whether the respondent has had symptoms as a result of gallstones or gallbladder problems and to determine whether the respondent received treatment for the gallbladder problem. The interviewer will provide the respondent with a show card containing a diagram of the upper body before asking the first question. Numbers that appear in parentheses after the answer choice are a skip pattern and direct the user to the next question in the series. These questions will not identify asymptomatic gallstones. For a more detailed assessment of gallbladder disease in adults, including identification of subjects with asymptomatic gallstones, see the National Health and Nutrition Examination Survey (NHANES) gallbladder ultrasound protocol in the Gastrointestinal Working Group Supplemental Information.
Tags:
Source: Regenstrief LOINC

Reference Documents:

ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey (NHANES) III. Adult Household Questionnaire. Section J: Gallbladder Disease. Pages 17-18.
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Everhart, J. E., Khare, M., Hill, M., & Maurer, K. R. (1999). Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology, 117, 632–639.
ID:
Title:
URI:
Provider Org:
Language Code:
en-US
Document:
Ruhl, C. E., & Everhart, J. E. (2000). Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology, 31, 299–303.

Properties:

Key:
Related Names
Value:
Assessment gallbladder disease protoDisDiseases
DzPanPanel
PANEL.PHENXPanlPnl
Point in timeRandom
Key:
Related Codes
Value:
Code SystemCodeCode TextCode Version
https://www.phenxtoolkit.org190201assessment_of_gallbladder_disease_and_related_conditions
Key:
Fully-Specified Name
Value:
ComponentPropertyTimeSystemScaleMethod
PhenX - assessment of gallbladder disease and related conditions protocol 190201-Pt^Patient-PhenX
Key:
Basic Attributes
Value:
ClassTypeFirst ReleasedLast UpdatedChange ReasonPanel Type
PANEL.PHENXClinicalVersion 2.36Version 2.66Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.Panel

Identifiers:

Source:
NLM
Id:
m1lYTzTnog
Version:
1.0
Source:
PhenX
Id:
190201
Version:
Source:
LOINC
Id:
62955-0
Version:
2.69